Naproxen Sodium

Product NDC
62207-750
11-digit product format
622070750
Labeler code
62207
Product ID
62207-750_7e93cb72-cb96-39f6-e053-2991aa0a367f
Type
HUMAN OTC DRUG
Nonproprietary name
Naproxen Sodium
Dosage form
TABLET
Route
ORAL
Labeler
Granules India Limited
Application
ANDA091353
Marketing category
ANDA
Marketing start
2011-09-30
Marketing end
0000-00-00
Substance
NAPROXEN SODIUM
Active strength
220 mg/1
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct62207-750IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-41IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-42IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-43IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-44IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-45IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-47IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-49IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-51IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-52IInactivated by FDA2026-07-31
excluded packagepackage62207-75062207-750-53IInactivated by FDA2026-07-31

Orange Book products#

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A091353-001NAPROXEN SODIUMNAPROXEN SODIUM220MGTABLET / ORAL2011-09-20

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Rapidol NaproxenNAPROXEN SODIUMPharmadel LLCc94c4b6e-a48b-cee5-e053-2995a90a49ac2026-03-20WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMGranules USA, Inc.8cb8030c-b281-315c-e053-2a95a90a36f02025-12-22WarningsExact identifier
NaproxenNAPROXENSafeway, Incf2a273f8-d623-dc2f-e053-2995a90a0c022025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMSafeway, Incf2a297c2-3898-5e47-e053-2995a90ab3cc2025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMTARGET CORPORATIONfdb87abd-3176-dd62-e053-6394a90a6fcc2025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMCVS1042b202-e8ee-1839-e063-6294a90ac90b2025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMCVS10429d07-de96-5542-e063-6294a90a73712025-12-19WarningsExact identifier
Dr Simi All Day Pain ReliefNAPROXEN SODIUMFarmacias De Similares TX LLC3c6d4bb5-eb6f-944b-e063-6294a90ae8de2025-08-15WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMBi-Mart6d5cecc9-5095-477b-bfc7-45b6e7e689f02025-03-01WarningsExact identifier
NAPROXEN SODIUMNAPROXEN SODIUMSPIRIT PHARMACEUTICALS,LLCa690dc39-95f2-4853-a291-05d7dc9a15512024-12-30WarningsExact identifier
Pain ReliefNAPROXEN SODIUMGobrands, Incae4bfa8c-ae41-4fcd-b584-872cc4d376832024-12-20WarningsExact identifier
PROXEN NP 660NAPROXEN SODIUMOPMX LLC09990b2f-202e-b4df-e063-6394a90a055b2023-12-27WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMGranules India Ltd95ba1722-60ed-4a83-9f26-50c4de8cf1802023-02-06WarningsExact identifier
All Day Pain ReliefNAPROXEN SODIUM TABLETS, 220 MGHealthLife of USA LLC7b0cb91e-5465-40ef-9f82-919f7d984f172017-06-01WarningsExact identifier

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

warnings

Warnings Allergy a lert: Naproxen sodium may cause severe skin reactions. Symptoms may include: hives facial swelling asthma (wheezing) shock skin reddening rash blisters. If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning : This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you: are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen or others) have 3 or more alcoholic drinks every day while using this product take more or for a longer time than directed Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Do not use if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery Ask a doctor before use if the stomach bleeding warning applies to you you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic you have problems or serious side effects from taking pain relievers or fever reducers Ask a doctor or pharmacist before use if you are under a doctor’s care for any serious condition taking aspirin for heart attack or stroke, because naproxen may decrease this benefit of aspirin taking any other drugs When using this product take with food or milk if stomach upset occurs Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing slurred speech leg swelling weakness in one part or side of body pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days you have difficulty swallowing it feels like the pill is stuck in your throat redness or swelling is present in the painful area any new symptoms appear If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or...

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fef6ad89-235f-4274-ba49-a8e53642473eProduct name220250225
87fed3e6-8fba-48ef-96b0-3a7fb54b96ffProduct name320230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8Product name120200623
e76dbbc1-775d-722c-08ff-ed45e8a80defProduct name320181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7cProduct name120140508
ce67e27d-1d21-5465-4409-b0662dd99d4dProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62207-750-41Naproxen Sodium24 in 1 BOTTLETABLET247
62207-750-42Naproxen Sodium50 in 1 BOTTLETABLET507
62207-750-43Naproxen Sodium43 in 1 BOTTLETABLET437
62207-750-44Naproxen Sodium150 in 1 BOTTLETABLET1507
62207-750-45Naproxen Sodium200 in 1 BOTTLETABLET2007
62207-750-47Naproxen Sodium500 in 1 BOTTLETABLET5007
62207-750-49Naproxen Sodium1000 in 1 BOTTLETABLET10007
62207-750-51Naproxen Sodium10 in 1 BOTTLETABLET107
62207-750-52Naproxen Sodium300 in 1 BOTTLETABLET3007
62207-750-53Naproxen Sodium400 in 1 BOTTLETABLET4007

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WONAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2NAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPNAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62207-750NAPROXEN SODIUM TABLET [GRANULES INDIA LIMITED]7Legacy NDC, 10 package rows20231213_28d602d3-7f53-4575-848d-0670ea557d2a.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
849574naproxen sodium 220 MG Oral TabletPSN28d602d3-7f53-4575-848d-0670ea557d2a7
849574naproxen sodium 220 MG Oral TabletSCD28d602d3-7f53-4575-848d-0670ea557d2a7
849574naproxen sodium 220 MG (as naproxen 200 MG) Oral TabletSY28d602d3-7f53-4575-848d-0670ea557d2a7

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
62207-750-416220707504124 in 1 BOTTLEHistorical
62207-750-426220707504250 in 1 BOTTLEHistorical
62207-750-436220707504343 in 1 BOTTLEHistorical
62207-750-4462207075044150 in 1 BOTTLEHistorical
62207-750-4562207075045200 in 1 BOTTLEHistorical
62207-750-4762207075047500 in 1 BOTTLEHistorical
62207-750-49622070750491000 in 1 BOTTLEHistorical
62207-750-516220707505110 in 1 BOTTLEHistorical
62207-750-5262207075052300 in 1 BOTTLEHistorical
62207-750-5362207075053400 in 1 BOTTLEHistorical